Abiopharma

CME GROUP INC. (CME)

Symbol	CME
Name	CME GROUP INC.
Sector	FINANCE
Region	North America
Industry	Investment Bankers/Brokers/Service
Address	20 SOUTH WACKER DRIVE, CHICAGO, Illinois, 60606, United States
Telephone	+1 312 930-1000
Fax	—
Email	—
Website	https://www.cmegroup.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001156375
Description	Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P/Dow Jones Indices LLC, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CMEs acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization. Additional info from NASDAQ: Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P/Dow Jones Indices LLC, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CMEs acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.

2026-04-29 18:50

New Form SCHEDULE 13G - CME GROUP INC. Filed: 2026-04-29 AccNo: 0002100119-26-000353 Size: 7 KB

2026-04-24 18:38

CME GROUP INC. (CME) Files Form 10-Q

2026-04-22 11:13

(50% Neutral) CME GROUP INC. (CME) Reports Q2 2026 Financial Results

2026-04-22 11:00

CME Group Inc. Reports Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2026

2026-03-30 21:30

Director SHEPARD WILLIAM R 🟢 acquired 1.5K shares of CME GROUP INC. (CME) at $297.38 Transaction Date: Mar 26, 2026 | Filing ID: 022028

2026-03-26 15:25

New Form SCHEDULE 13G/A - CME GROUP INC. Filed: 2026-03-26 AccNo: 0000102909-26-000484 Size: 7 KB

2026-03-23 17:19

New Form DEFA14A - CME GROUP INC. Filed: 2026-03-23 AccNo: 0001628280-26-020514 Size: 2 MB

2026-03-23 10:39

New Form 4/A - CME GROUP INC. Filed: 2026-03-23 AccNo: 0001628280-26-020364 Size: 5 KB

2026-03-19 13:47

Marcus Jonathan L 🔴 sold 3.3K shares of CME GROUP INC. (CME) at $333.37 ($1.1M) Transaction Date: Mar 17, 2026 | Filing ID: 019658

2026-03-17 20:03

📋 JONATHAN MARCUS (Officer) plans to sell 3K shares of CME GROUP INC. (at $313.37 each, total $1.0M) Filed: Mar 17, 2026 | ID: 002700